相似文献
1
The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects.
Br J Cancer. 1982 May;45(5):655-69. doi: 10.1038/bjc.1982.106.
2
3
Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.
BMC Cancer. 2016 May 12;16:307. doi: 10.1186/s12885-016-2345-7.
4
Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
Breast Cancer Res Treat. 2013 Jul;140(1):93-104. doi: 10.1007/s10549-013-2617-8. Epub 2013 Jun 27.
5
The Cancer Research Campaign (King's/Cambridge) trial for early breast cancer: an analysis of the radiotherapy data.
Br J Radiol. 1984 Apr;57(676):309-16. doi: 10.1259/0007-1285-57-676-309.
6
Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
Radiother Oncol. 2013 Aug;108(2):259-65. doi: 10.1016/j.radonc.2013.06.028. Epub 2013 Jul 25.
7
Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Eur J Surg Oncol. 2017 Apr;43(4):672-679. doi: 10.1016/j.ejso.2016.12.011. Epub 2017 Jan 16.
8
[The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery].
Zhonghua Zhong Liu Za Zhi. 2018 May 23;40(5):347-351. doi: 10.3760/cma.j.issn.0253-3766.2018.05.006.
9
Pooled long-term outcomes from two randomized trials of axillary node sampling with axillary radiotherapy versus axillary node clearance in patients with operable node-positive breast cancer.
Br J Surg. 2016 Jan;103(1):81-7. doi: 10.1002/bjs.9952.
10
[A new perspective on axillary dissection in situations of metastatic sentinel node].
Rozhl Chir. 2017 Fall;96(8):346-352.
引用本文的文献
1
Analysis of Spatial Distribution and Prognostic Value of Different Pan Cytokeratin Immunostaining Intensities in Breast Tumor Tissue Sections.
Int J Mol Sci. 2020 Jun 22;21(12):4434. doi: 10.3390/ijms21124434.
2
Size and Shape Filtering of Malignant Cell Clusters within Breast Tumors Identifies Scattered Individual Epithelial Cells as the Most Valuable Histomorphological Clue in the Prognosis of Distant Metastasis Risk.
Cancers (Basel). 2019 Oct 22;11(10):1615. doi: 10.3390/cancers11101615.
3
Clinicopathological characteristics of infiltrating lobular breast carcinoma in elderly women: Preliminary results.
Mol Clin Oncol. 2015 Nov;3(6):1337-1340. doi: 10.3892/mco.2015.625. Epub 2015 Aug 28.
4
Effect of specialized diagnostic assessment units on the time to diagnosis in screen-detected breast cancer patients.
Br J Cancer. 2015 May 26;112(11):1744-50. doi: 10.1038/bjc.2015.147. Epub 2015 May 5.
5
Computer-based image studies on tumor nests mathematical features of breast cancer and their clinical prognostic value.
PLoS One. 2013 Dec 12;8(12):e82314. doi: 10.1371/journal.pone.0082314. eCollection 2013.
6
Genomic approaches in breast cancer research.
Brief Funct Genomics. 2013 Sep;12(5):391-6. doi: 10.1093/bfgp/elt019. Epub 2013 Jun 20.
7
Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis.
Genome Biol. 2013 Apr 29;14(4):R34. doi: 10.1186/gb-2013-14-4-r34.
8
Statistical association of basal cell keratins with metastasis-inducing proteins in a prognostically unfavorable group of sporadic breast cancers.
Am J Pathol. 2011 Aug;179(2):1061-72. doi: 10.1016/j.ajpath.2011.04.022. Epub 2011 Jun 14.
9
Heterogeneity of invasive ductal carcinoma: proposal for a hypothetical classification.
J Korean Med Sci. 2006 Jun;21(3):460-8. doi: 10.3346/jkms.2006.21.3.460.
10
Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer.
Br J Cancer. 2002 Nov 18;87(11):1275-80. doi: 10.1038/sj.bjc.6600617.
本文引用的文献
1
Further studies on prognosis of breast carcinoma.
Br J Cancer. 1950 Dec;4(4):347-67. doi: 10.1038/bjc.1950.34.
2
Prognosis in carcinoma of the breast.
Br J Cancer. 1950 Sep;4(3):259-88. doi: 10.1038/bjc.1950.26.
3
Survival in breast cancer cases in relation to the structure of the primary tumor and regional lymph nodes.
Surg Gynecol Obstet. 1955 May;100(5):543-51.
4
Inflammation and prognosis in breast cancer; a search for host resistance.
Cancer. 1959 Jul-Aug;12(4):714-20. doi: 10.1002/1097-0142(195907/08)12:4<714::aid-cncr2820120414>3.0.co;2-b.
5
Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.
Br J Cancer. 1957 Sep;11(3):359-77. doi: 10.1038/bjc.1957.43.
6
Histological grading in carcinoma of the breast.
Br J Cancer. 1966 Mar;20(1):36-40. doi: 10.1038/bjc.1966.5.
7
Possible host resistance in carcinoma of the breast: a histological study.
Br J Cancer. 1968 Sep;22(3):383-401. doi: 10.1038/bjc.1968.47.
8
Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years.
Br Med J. 1970 Jul 25;3(5716):181-8. doi: 10.1136/bmj.3.5716.181.
9
Cancer of the breast: size of neoplasm and prognosis.
Cancer. 1969 Nov;24(5):1071-80. doi: 10.1002/1097-0142(196911)24:5<1071::aid-cncr2820240533>3.0.co;2-h.
10
Organization of clinical trial on national scale: management of early cancer of the breast.
Br Med J. 1972 Nov 25;4(5838):476-8. doi: 10.1136/bmj.4.5838.476.
Zotero 插件